问止中医拟赴港上市，约90%诊疗收入来源于线上渠道

Core Viewpoint - The company, Wenzhi Traditional Chinese Medicine, has re-submitted its listing application to the Hong Kong Stock Exchange after previous attempts were unsuccessful. The company primarily generates revenue from TCM medical services, with a significant portion coming from online channels. Financial Performance - The company reported net losses of 154 million yuan, 194 million yuan, 45 million yuan, and 44 million yuan for the years 2022, 2023, 2024, and the first five months of 2025, respectively. It is expected to continue incurring losses in 2025, mainly due to fair value losses on convertible redeemable preferred shares [1][2] - Revenue figures for the same periods were 62 million yuan, 189 million yuan, 236 million yuan, and 100 million yuan, with approximately 90% of the diagnostic revenue coming from online channels [1][2] Service Offerings - The largest share of the company's TCM medical service revenue comes from general practice, accounting for 48.2% of total TCM service revenue. The company has developed treatment plans for over 3,000 types of diseases and has accumulated more than 1 million clinical cases [1] Operational Details - As of May 31, 2025, the company operates 11 offline clinics, including one outpatient department, and employs 93 full-time physicians. The average years of practice for the physicians is approximately five years [3]